GB9226768D0 - Vaccines - Google Patents

Vaccines

Info

Publication number
GB9226768D0
GB9226768D0 GB929226768A GB9226768A GB9226768D0 GB 9226768 D0 GB9226768 D0 GB 9226768D0 GB 929226768 A GB929226768 A GB 929226768A GB 9226768 A GB9226768 A GB 9226768A GB 9226768 D0 GB9226768 D0 GB 9226768D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929226768A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GB929226768A priority Critical patent/GB9226768D0/en
Publication of GB9226768D0 publication Critical patent/GB9226768D0/en
Priority to MX9307998A priority patent/MX9307998A/en
Priority to AU58144/94A priority patent/AU672870B2/en
Priority to CA002152256A priority patent/CA2152256A1/en
Priority to JP6514805A priority patent/JPH08504592A/en
Priority to KR1019950702600A priority patent/KR950704494A/en
Priority to PCT/EP1993/003626 priority patent/WO1994014962A1/en
Priority to EP94903844A priority patent/EP0675957A1/en
Priority to NZ259362A priority patent/NZ259362A/en
Priority to ZA939564A priority patent/ZA939564B/en
Priority to CN93119996A priority patent/CN1095106A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB929226768A 1992-12-23 1992-12-23 Vaccines Pending GB9226768D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB929226768A GB9226768D0 (en) 1992-12-23 1992-12-23 Vaccines
MX9307998A MX9307998A (en) 1992-12-23 1993-12-15 PROTEIN OF VARICELA-ZOSTER VIRUSES, DERIVED FROM THE SAME AND VACCINE THAT CONTAINS IT.
NZ259362A NZ259362A (en) 1992-12-23 1993-12-17 Varicella zoster virus immediate early protein 175 (vzv iep 175) and derivatives, its production and use
JP6514805A JPH08504592A (en) 1992-12-23 1993-12-17 Varicella-zoster virus (VZV) vaccine
CA002152256A CA2152256A1 (en) 1992-12-23 1993-12-17 Vaccines against varicella-zoster virus (vzv)
AU58144/94A AU672870B2 (en) 1992-12-23 1993-12-17 Vaccines against varicella-zoster virus (VZV)
KR1019950702600A KR950704494A (en) 1992-12-23 1993-12-17 Vaccine against varicella-zoster virus (VZV) (VACCINES AGAINST VARICELLAZOSTER VIRUS (VZV))
PCT/EP1993/003626 WO1994014962A1 (en) 1992-12-23 1993-12-17 Vaccines against varicella-zoster virus (vzv)
EP94903844A EP0675957A1 (en) 1992-12-23 1993-12-17 Vaccines against varicella-zoster virus (vzv)
ZA939564A ZA939564B (en) 1992-12-23 1993-12-21 Vaccines.
CN93119996A CN1095106A (en) 1992-12-23 1993-12-22 Vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226768A GB9226768D0 (en) 1992-12-23 1992-12-23 Vaccines

Publications (1)

Publication Number Publication Date
GB9226768D0 true GB9226768D0 (en) 1993-02-17

Family

ID=10727070

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929226768A Pending GB9226768D0 (en) 1992-12-23 1992-12-23 Vaccines

Country Status (11)

Country Link
EP (1) EP0675957A1 (en)
JP (1) JPH08504592A (en)
KR (1) KR950704494A (en)
CN (1) CN1095106A (en)
AU (1) AU672870B2 (en)
CA (1) CA2152256A1 (en)
GB (1) GB9226768D0 (en)
MX (1) MX9307998A (en)
NZ (1) NZ259362A (en)
WO (1) WO1994014962A1 (en)
ZA (1) ZA939564B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9901254D0 (en) * 1999-01-20 1999-03-10 Smithkline Beecham Biolog Vaccines
CN110343722A (en) * 2019-07-03 2019-10-18 上海大学 A method of varicella virus v-Oka plants of truncated-type glycoprotein E of recombinant expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69017769T2 (en) * 1989-06-27 1995-07-13 Smithkline Beecham Biologicals S.A., Rixensart Links.
JP3026029B2 (en) * 1991-04-26 2000-03-27 財団法人阪大微生物病研究会 Recombinant varicella virus and its production method

Also Published As

Publication number Publication date
EP0675957A1 (en) 1995-10-11
ZA939564B (en) 1994-08-15
CA2152256A1 (en) 1994-07-07
NZ259362A (en) 1996-10-28
WO1994014962A1 (en) 1994-07-07
MX9307998A (en) 1994-08-31
AU672870B2 (en) 1996-10-17
JPH08504592A (en) 1996-05-21
CN1095106A (en) 1994-11-16
AU5814494A (en) 1994-07-19
KR950704494A (en) 1995-11-20

Similar Documents

Publication Publication Date Title
AP9300541A0 (en) Vaccines
AP9300530A0 (en) Vaccines
ZA947828B (en) Vaccines
IL99899A0 (en) Vaccines
GB9325496D0 (en) Vaccines
GB9215233D0 (en) Vaccines
GB9201023D0 (en) Vaccines
ZA93919B (en) Vaccines
GB9213559D0 (en) Vaccines
GB9214871D0 (en) Vaccines
ZA948685B (en) Vaccines
GB9322808D0 (en) Vaccines
GB9226768D0 (en) Vaccines
GB9211081D0 (en) Vaccines
ZA935281B (en) Vaccines
GB9226283D0 (en) Vaccines
GB9211318D0 (en) Vaccines
GB9221891D0 (en) Vaccines
GB9216317D0 (en) Vaccines
GB9220360D0 (en) Vaccines
GB9218833D0 (en) Vaccines
GB9217635D0 (en) Vaccines
GB9206789D0 (en) Vaccine
GB9206786D0 (en) Vaccine
GB9206797D0 (en) Vaccine